Venkat Ramanan, Ph.D.

Venkat Ramanan has served as Chief Financial Officer of Immatics since October 2025.

In this role, he provides strategic and operational finance leadership to support the company’s growth and transition into a commercial-stage biopharmaceutical organization.

Venkat has more than 25 years of experience in finance, strategy and operations across the biopharmaceutical industry. Before joining Immatics, he served as CFO of Anthos Therapeutics, a Novartis company. Prior to that, he was CFO of Turnstone Biologics, where he led the company through its IPO. Earlier, he held senior finance and business leadership roles at Seagen, Gilead Sciences and Amgen, where he enabled multiple successful product launches, global expansion and strategic transactions.

Venkat holds a Ph.D. in Engineering Mechanics from The Ohio State University.